Daxor Corporation Common Stock

DXR

Daxor Corporation (DXR) is a medical device company specializing in blood volume measurement technology. It is known for its BVA-100 Blood Volume Analyzer, which provides precise blood volume readings to aid in the diagnosis and management of various health conditions, including anemia, heart failure, and blood disorders. The company has a long-standing history of developing and commercializing innovative diagnostic tools within the healthcare industry.

$13.19 0.00 (0.00%)
Dividend Yield 0.23%
Payout Frequency Yearly

Dividend History

Pay DateAmountEx-DateRecord Date
January 12, 2018$0.032018-01-052018-01-08
December 29, 2016$0.032016-12-202016-12-22
December 29, 2015$0.042015-12-182015-12-22
December 26, 2014$0.032014-12-042014-12-08
December 27, 2013$0.052013-12-052013-12-09

Dividends Summary

Company News

Daxor CEO Michael Feldschuh to Engage Investors at Exclusive Maxim Growth Summit
GlobeNewswire Inc. • Michael Feldschuh • October 21, 2025

Daxor Corporation will participate in the Maxim Growth Summit in New York City, presenting its innovative Blood Volume Analysis (BVA) technology to institutional investors and featuring one-on-one meetings with potential investors.

Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga • Lisa Levin • May 22, 2023

Gainers Greenhill & Co., Inc. (NYSE: GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share. AVROBIO, Inc. (NASDAQ: AVRO) gained 93.5% to $1.50 after the company announced it would sell its gene therapy program to Novartis for $87.5 million. Microbot Medical Inc. (NASDAQ: MBOT) rose 66% to $2.04...

Related Companies